Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Mattsson

Showing results (211-220 of 258) with videos related to

Pageof 26
Sort By:
Transplantation and Cellular Therapy|October 30, 2025
Herpes Zoster Frequency and Adjuvanted Recombinant Zoster Vaccination after Allogeneic Hematopoietic Cell TransplantationVictoria G Hall, Caden Chiarello, Mats Remberger, et al.
Transplantation and Cellular Therapy|February 9, 2022
Improving Safety and Outcomes After Allogeneic Hematopoietic Cell Transplantation: A Single-Center ExperienceMaria Queralt Salas, Ivan Pasic, Mats Remberger, et al.
Transplantation and Cellular Therapy|April 22, 2024
Treosulfan- Versus Busulfan-based Conditioning in Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Single-center Retrospective Propensity Score-matched Cohort StudyIvan Pasic, Tommy Alfaro Moya, Mats Remberger, et al.
European Journal of Haematology|September 25, 2019
Impact of CD34+ cell dose on reduced intensity conditioning regimen haploidentical hematopoietic stem cell transplantationMaria Queralt Salas, Eshetu G Atenafu, Maria Rhida Bautista, et al.
Hematology/Oncology and Stem Cell Therapy|December 2, 2021
Outcomes of Patients Diagnosed With Chronic Lymphocytic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results From a Tertiary Care CenterSwe M Linn, Ram V Nampoothiri, Carol Chen, et al.
British Journal of Haematology|July 19, 2025
Impact of graft-versus-host disease prophylaxis on second primary malignancies after allogeneic haematopoietic stem cell transplantationNihar Desai, Eshrak Al-Shaibani, Tommy Alfaro-Moya, et al.
Transplantation and Cellular Therapy|October 17, 2021
Bloodstream Infections and Outcomes Following Allogeneic Hematopoietic Cell Transplantation: A Single-Center StudyAbel Santos Carreira, Maria Queralt Salas, Mats Remberger, et al.
Bone Marrow Transplantation|June 3, 2025
Prolonged length of stay in high-risk patients undergoing allogeneic stem cell transplantation: a call to action for addressing healthcare challengesAyman Sayyed, Igor Novitzky-Basso, Mats Remberger, et al.
Cancers|February 26, 2025
Exploring Outcomes by Ethnicity in Allogeneic Hematopoietic Cell TransplantationElizabeth Herrity, Sanjay Singhabahu, Mats Remberger, et al.
Bone Marrow Transplantation|October 22, 2020
Vitamin D levels and busulphan kinetics in patients undergoing hematopoietic stem cell transplantation, a multicenter studyAhmed El-Serafi, Rui He, Wenyi Zheng, et al.
Pageof 26

Showing results (211-220 of 258) with videos related to

Sort By:
Pageof 26
Transplantation and Cellular Therapy|October 30, 2025
Herpes Zoster Frequency and Adjuvanted Recombinant Zoster Vaccination after Allogeneic Hematopoietic Cell TransplantationVictoria G Hall, Caden Chiarello, Mats Remberger, et al.
Transplantation and Cellular Therapy|February 9, 2022
Improving Safety and Outcomes After Allogeneic Hematopoietic Cell Transplantation: A Single-Center ExperienceMaria Queralt Salas, Ivan Pasic, Mats Remberger, et al.
Transplantation and Cellular Therapy|April 22, 2024
Treosulfan- Versus Busulfan-based Conditioning in Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Single-center Retrospective Propensity Score-matched Cohort StudyIvan Pasic, Tommy Alfaro Moya, Mats Remberger, et al.
European Journal of Haematology|September 25, 2019
Impact of CD34+ cell dose on reduced intensity conditioning regimen haploidentical hematopoietic stem cell transplantationMaria Queralt Salas, Eshetu G Atenafu, Maria Rhida Bautista, et al.
Hematology/Oncology and Stem Cell Therapy|December 2, 2021
Outcomes of Patients Diagnosed With Chronic Lymphocytic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results From a Tertiary Care CenterSwe M Linn, Ram V Nampoothiri, Carol Chen, et al.
British Journal of Haematology|July 19, 2025
Impact of graft-versus-host disease prophylaxis on second primary malignancies after allogeneic haematopoietic stem cell transplantationNihar Desai, Eshrak Al-Shaibani, Tommy Alfaro-Moya, et al.
Transplantation and Cellular Therapy|October 17, 2021
Bloodstream Infections and Outcomes Following Allogeneic Hematopoietic Cell Transplantation: A Single-Center StudyAbel Santos Carreira, Maria Queralt Salas, Mats Remberger, et al.
Bone Marrow Transplantation|June 3, 2025
Prolonged length of stay in high-risk patients undergoing allogeneic stem cell transplantation: a call to action for addressing healthcare challengesAyman Sayyed, Igor Novitzky-Basso, Mats Remberger, et al.
Cancers|February 26, 2025
Exploring Outcomes by Ethnicity in Allogeneic Hematopoietic Cell TransplantationElizabeth Herrity, Sanjay Singhabahu, Mats Remberger, et al.
Bone Marrow Transplantation|October 22, 2020
Vitamin D levels and busulphan kinetics in patients undergoing hematopoietic stem cell transplantation, a multicenter studyAhmed El-Serafi, Rui He, Wenyi Zheng, et al.
Pageof 26